We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Releases Guidance on Submission of Pharmacogenomic Information
Canada Releases Guidance on Submission of Pharmacogenomic Information
March 6, 2007
Health Canada has published final guidance for manufacturers on how and when to submit pharmacogenomic (PGx) information in support of an application for a medical device, drug or biologic product intended for human use.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor